ConditionsOrgan PreservationBrain Reperfusion or Regain of Brain Function During Normothermic Regional Perfusion
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorUniversity of British Columbia
About this trial
The aim of this study is to demonstrate that cerebral blood flow and brain function do not resume after death declaration in organ donors who undergo normothermic regional perfusion to restore organ function following death determination by circulatory criteria, when appropriate safeguards are applied.
To assess the absence of cerebral perfusion and function, investigators will use continuous and comprehensive multimodal neuromonitoring throughout the withdrawal of life-sustaining therapies, the dying process and the NRP procedure.
Eligibility criteria
Qualifiers
Age > 18;
Planned DCD within the next 96 hours.
Disqualifiers
Coagulopathy (International normalized ratio > 1.5, prothrombin time > 45 seconds, platelets < 50);
Therapeutic anticoagulant medication administration.
Trial design
Treatments tested in this trial
- Neuromonitoring
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov